Trials / Completed
CompletedNCT01767324
Site Selection for Intracutaneous Saline Delivery
Exploratory Evaluation of Injection Sites in Healthy Subjects Receiving Saline Delivered by a Non-Significant Risk Investigational Device Utilizing a Micro-Needle Array
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- FluGen Inc · Industry
- Sex
- All
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The goal of this exploratory study is to select the optimal body site for intracutaneous delivery of 0.5 milliliters of saline from the FLUGEN 101.2 microneedle-based device.
Detailed description
Test ability to inject saline into various sites on body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Injection to deltoid | Deliver 0.5 milliliters of saline intradermally |
| DEVICE | Injection to forearm | Deliver 0.5 milliliters of saline intradermally |
| DEVICE | Injection to thigh | Deliver 0.5 milliliters of saline intradermally |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2013-01-14
- Last updated
- 2017-08-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01767324. Inclusion in this directory is not an endorsement.